Europe Molecular Diagnostics Industry Report 2025-2033, Industry Growth, Share, Size, Demand and Forecast

Europe Molecular Diagnostics Market Overview 

Market Size in 2024: USD 5.3 Billion

Market Forecast in 2033: USD 8.6 Billion

Market Growth Rate: 5.3% (2025-2033)

According to the latest report by IMARC Group, the Europe molecular diagnostics market size was valued at USD 5.3 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 8.6 Billion by 2033, exhibiting a CAGR of 5.3% from 2025-2033.

Europe Molecular Diagnostics Industry Trends and Drivers:

As clinical laboratories and healthcare professionals increasingly embrace next-generation testing systems to provide quicker, more precise results, the Europe molecular diagnostics market is progressing gradually. Rising demand for personalized medicine, which depends on molecular-level understanding of patient biology to create bespoke treatment approaches, is underlying this expansion. Early detection and targeted intervention are supported by hospitals and diagnostic centers using high-throughput techniques like PCR, DNA sequencing, and isothermal amplification. These platforms are helping to quickly identify infectious agents, oncogenic mutations, and inherited disorders, hence improving patient outcomes and lowering healthcare expenses. Point-of-care testing equipment shows a notable rise as molecular diagnostics develop beyond central laboratories, providing real-time results for physicians and improving decision-making in serious care situations. In rural and outpatient settings, where quick diagnostics are revolutionizing access to timely care, this decentralization is especially important.

Further fueling market expansion is the extensive usage of molecular diagnostics in several medical fields. With sophisticated tests now detecting several pathogens simultaneously, including viral, bacterial, and fungal strains, infectious disease detection is still a main application area. One high-impact section developing is oncology, where molecular profiling is informing chemotherapy and immunotherapy decisions. Among prospective parents as well as people looking for predicted knowledge on inherited diseases, genetic testing is also becoming popular. Strong demand for reagents, test kits, and automation-ready tools is being driven by these growing applications. Software and data analytics technologies are concurrently helping to interpret intricate genomic data, back precision medicine programs, and boost laboratory workflow efficiency, hence assuming an increasing importance. Reflecting the growing convergence of diagnostics with digital health environments across Europe, laboratories and hospitals are investing in interoperable digital solutions to simplify test ordering, results integration, and clinical decision support.

Market variety and specialization are being enhanced by nation-specific changes. With a heavy emphasis on including diagnostics into national healthcare repayment systems, Germany is hastening investments in genomic infrastructure. France is using collaborations between public research institutions and biotechnology companies to give innovation in oncology diagnostics top priority. Through national health initiatives, the UK is stressing genetic testing by increasing whole-genome sequencing and hereditary risk screening access. Supported by tech-forward healthcare systems, Nordic nations are promoting digital diagnostics platforms and home-based molecular testing. Growing investment in diagnostic labs in Eastern Europe is enhancing disease surveillance and early detection capabilities. Together, these regional dynamics are establishing the Europe molecular diagnostics industry as a foundation of precision medicine and value-based healthcare delivery.

Download sample copy of the Report: https://www.imarcgroup.com/europe-molecular-diagnostics-market/requestsample

Europe Molecular Diagnostics Industry Segmentation:

The report has segmented the market into the following categories:

Product Insights:

• Reagents and Kits
• Instruments
• Software and Services

Technology Insights:

• Polymerase Chain Reactions (PCR)
• Hybridization
• DNA Sequencing
• Microarray
• Isothermal Nucleic Acid Amplification Technology (INAAT)
• Others

Application Insights:

• Infectious Diseases Diagnostics
• Oncology
• Genetic Testing
• Blood Screening
• Others

End User Insights:

• Hospitals
• Laboratories
• Others

Country Insights:

• Germany
• France
• United Kingdom
• Italy
• Spain
• Others

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Key highlights of the Report:

• Market Performance (2019-2024)
• Market Outlook (2025-2033)
• COVID-19 Impact on the Market
• Porter’s Five Forces Analysis
• Strategic Recommendations
• Historical, Current and Future Market Trends
• Market Drivers and Success Factors
• SWOT Analysis
• Structure of the Market
• Value Chain Analysis
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Ask analyst for your customized sample: https://www.imarcgroup.com/request?type=report&id=11051&flag=C

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:  

IMARC Group 

134 N 4th St. Brooklyn, NY 11249, USA 

Email: sales@imarcgroup.com 

Tel No:(D) +91 120 433 0800 

United States: +1-631-791-1145